R&D facility

04.11.2022 • News

Cambrex Invests in US R&D Facility

Cambrex is investing in a new R&D facility in Minneapolis, Minnesota, USA, expanding its capacity for small molecule development and manufacturing.

03.09.2015 • Topics • Strategy

AkzoNobel Opens €7 Million Fire Protection R&D Facility

Top-Feature

Bio-Rad Laboratories

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

CHEManager International c/o Wiley-VCH GmbH

Digitalization in the Chemical Industry

Free Expert Insights

Advancements in Bispecific Antibody Development

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.